169 related articles for article (PubMed ID: 2085389)
1. Solution phase conformation studies of the prekallikrein binding domain of high molecular weight kininogen.
Scarsdale JN; Harris RB
J Protein Chem; 1990 Oct; 9(5):647-59. PubMed ID: 2085389
[TBL] [Abstract][Full Text] [Related]
2. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
You JL; Scarsdale JN; Harris RB
J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
[TBL] [Abstract][Full Text] [Related]
3. Conformational analysis of synthetic peptides encompassing the factor XI and prekallikrein overlapping binding domains of high molecular weight kininogen.
You JL; Page JD; Scarsdale JN; Colman RW; Harris RB
Peptides; 1993; 14(5):867-76. PubMed ID: 8284263
[TBL] [Abstract][Full Text] [Related]
4. Mapping of the prekallikrein-binding site of human H-kininogen by ligand screening of lambda gt11 expression libraries. Mimicking of the predicted binding site by anti-idiotypic antibodies.
Vogel R; Kaufmann J; Chung DW; Kellermann J; Müller-Esterl W
J Biol Chem; 1990 Jul; 265(21):12494-502. PubMed ID: 1695630
[TBL] [Abstract][Full Text] [Related]
5. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
Tait JF; Fujikawa K
J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
[TBL] [Abstract][Full Text] [Related]
6. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy.
Weisel JW; Nagaswami C; Woodhead JL; DeLa Cadena RA; Page JD; Colman RW
J Biol Chem; 1994 Apr; 269(13):10100-6. PubMed ID: 8144509
[TBL] [Abstract][Full Text] [Related]
7. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain.
Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W
J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159
[TBL] [Abstract][Full Text] [Related]
8. Physical and biological significance of peptide sequences mediating the interaction between high molecular weight kininogen and plasma prekallikrein.
Colman RW; Lin Y; Yan WY; McCrae KR; Shenoy SS; Harris RB
Immunopharmacology; 1997 Jun; 36(2-3):193-200. PubMed ID: 9228546
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence for multifacial contacts between high molecular weight kininogen and plasma prekallikrein.
Lin Y; Shenoy SS; Harris RB; Colman RW
Biochemistry; 1996 Oct; 35(39):12945-9. PubMed ID: 8841140
[TBL] [Abstract][Full Text] [Related]
10. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain.
Page JD; You JL; Harris RB; Colman RW
Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the H-kininogen binding site exposed by the prekallikrein heavy chain.
Herwald H; Hock H; Jahnen-Dechent W; Müller-Esterl W
Agents Actions Suppl; 1992; 38 ( Pt 1)():225-32. PubMed ID: 1466274
[No Abstract] [Full Text] [Related]
12. Structures of factor XI and prekallikrein bound to domain 6 of high-molecular weight kininogen reveal alternate domain 6 conformations and exosites.
Li C; Barroeta AB; Wong SS; Kim HJ; Pathak M; Dreveny I; Meijers JCM; Emsley J
J Thromb Haemost; 2023 Sep; 21(9):2378-2389. PubMed ID: 37068593
[TBL] [Abstract][Full Text] [Related]
13. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity.
Tait JF; Fujikawa K
J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985
[TBL] [Abstract][Full Text] [Related]
14. Fourier transform infrared (FT-IR) spectroscopic studies of peptide models for interaction of the binding regions of high molecular weight kininogen and prekallikrein.
Lin Y; Li W; Wu J; Zhang H; Colman RW
Thromb Res; 1998 Apr; 90(2):65-72. PubMed ID: 9684759
[TBL] [Abstract][Full Text] [Related]
15. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
Shimada T; Kato H; Maeda H; Iwanaga S
J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
[TBL] [Abstract][Full Text] [Related]
16. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.
Thompson RE; Mandle R; Kaplan AP
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905
[TBL] [Abstract][Full Text] [Related]
17. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn.
Dyson HJ; Rance M; Houghten RA; Lerner RA; Wright PE
J Mol Biol; 1988 May; 201(1):161-200. PubMed ID: 2843644
[TBL] [Abstract][Full Text] [Related]
18. Localization of the high molecular weight kininogen binding site in the heavy chain of human factor XI to amino acids phenylalanine 56 through serine 86.
Baglia FA; Jameson BA; Walsh PN
J Biol Chem; 1990 Mar; 265(7):4149-54. PubMed ID: 2105959
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity.
Reddigari SR; Kaplan AP
Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143
[TBL] [Abstract][Full Text] [Related]
20. Sequential proton NMR resonance assignments, circular dichroism, and structural properties of a 50-residue substrate-binding peptide from DNA polymerase I.
Mullen GP; Vaughn JB; Mildvan AS
Arch Biochem Biophys; 1993 Feb; 301(1):174-83. PubMed ID: 8442659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
